In the media 23 June 2021 Johnson & Johnson: The Leading Healthcare Group at the Forefront of Open Innovation Read full story
Partner news 17 June 2021 Apollo Therapeutics Completes $145 Million Financing Led by Patient Square Capital to Expand and Advance Portfolio-Based Drug Development Read full story
In the media 10 June 2021 Michael Hübner – New Venture Lead, Johnson & Johnson Innovation Switzerland Read full story
